Evaluation of Blood Flow Characteristics in Glaucoma Using Optical Coherence Tomography Angiography (OCT-A).
Terminated
- Conditions
- Glaucoma
- Registration Number
- NCT02757677
- Lead Sponsor
- Swiss Vision Network
- Brief Summary
The investigators aim to evaluate the efficacy of the new Optical Coherence Tomography based Angiography (OCT-A) softwares in the diagnosis and management of glaucoma.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
- Diagnosis of open angle glaucoma (OAG) including pseudo-exfoliative and pigmentary glaucoma.
- Documented glaucomatous visual field damage (in the previous 12 months with mean defect (MD) > 2.0 dB)
- Structural and/or functional glaucomatous damage
- Have given written informed consent, prior to any investigational procedures
Exclusion Criteria
- Patients with allergy to corneal anesthetic
- Patients not able to understand the character and individual consequences of the investigation
- Participation in other clinical research within the last 4 weeks
- Other diseases that may cause visual field loss or optic disc abnormalities
- Refractive error of > +3.00D or < -7.00D
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Macular and optic nerve head bloodflow, as measured by OCT-A macular and optic nerve head vessel density (%) Up to 3 years
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Glaucoma center, Montchoisi clinic
🇨🇭Lausanne, Switzerland
Glaucoma center, Montchoisi clinic🇨🇭Lausanne, Switzerland